New drugs like CAR-T cell cancer therapies are coming online. CMS reimbursement and regulations surrounding these innovations will be a case study in how our health care system responds.
This blog contains general information and does not constitute the rendering of legal, accounting, investment, tax, or other professional services. Consult with your advisors regarding the applicability of this content to your specific circumstances.
Want to learn more? Complete the form below and we'll be in touch. If you are unable to see the form below, please complete your submission here.Contact us